Author: Scott Welch
A new experimental GLP-1 drug, in pill form, could transform the weight loss drug boom. Eli Lilly’s new experimental pill called orforglipron, helped patients shed weight and control blood sugar as well as blockbuster drug Ozempic in a trial of diabetes patients, and the company said it expects to seek regulatory approvals by the end ...
Preventing a cancer diagnosis is a top health goal for many – and what people eat and drink can potentially play a big role. Matcha, a type of green tea that’s also a popular coffee alternative, may help aid in cancer prevention, according to some experts and recent research. Matcha can have great benefits for overall ...
Department of Health and Human Services (HHS) reorganization plans appear to have been revealed through a leaked Office of Management and Budget (OMB) document.
The wide-ranging order requires the Department of Health and Human Services to seek public comment on the drug price negotiation program, which effectively requires manufacturers to agree to lower prices for certain drugs, for potential changes in upcoming years.
Approximately two years after the federal government declared the COVID-19 emergency over, state and local health officials are feeling impacts of the administration’s restructuring.
Starting in 5 days, the Department of Health and Human Services (HHS) may begin slashing regulations it considers to be unlawful or to exceed the agency’s authority, according to a memorandum sent by the president on Wednesday.
An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump administration disclosed Monday.
California is projected to experience the largest potential losses in Medicaid coverage if federal work requirements are enacted.
The Centers for Medicare and Medicaid Services (CMS) will restrict federal funds for state-based programs that go toward certain priorities like rural broadband and student loan repayments. The department is looking to return to the “core mission of Medicaid” by rejecting, or not extending, federal matching fund requests for designated state health programs (DSHPs) and ...
Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government’s reimbursement rates for Medicare Advantage plans in 2026 signaled some relief for a sector burdened with steep medical costs. Medicare-focused insurer Humana (HUM.N), opens new tab led gains with a 16% jump, while other health insurers including UnitedHealth Group (UNH.N), opens new tab, ...